<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220211053997N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-19</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Effect of lidocaine, zinc acetate and tannic acid on gag reflex</public_title>
      <acronym></acronym>
      <scientific_title>Comparative study of the effect of three mucous adhesives containing lidocaine, zinc acetate and tannic acid on gag reflex in dental patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>228</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61954</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: For randomization, given that we want the number of samples assigned to four groups to be the same at any time, the block random division method is used. For this purpose, first all four combinations are written, which includes 24 modes. Then, considering that the sample size in each group is 57, 57 times from this combination of four are selected by replacing the sample. For this, the binary sequence in the random number table is used. Binary combinations that are outside the range 01 to 24 are not considered, Blinding description: The present study is conducted in a double-blind manner with a one-to-one allocation ratio.
Blind people in this study are researchers, participants and outcome assessors.
The study is conducted by a doctor (outcome assessor) who is firstly unaware of the research hypothesis and secondly is not aware of how people are assigned to intervention groups and the type of mucosal adhesive.
The patient (participant) is also unaware of the research hypothesis and the type of mucosal adhesive, due to the same shape and color of the adhesives.
The patient enters the study with his consent, but nothing is told to the patient regarding the decreasing or increasing effect of adhesives on the gag reflex. Also, the patient is unaware of the type of adhesive that is used for him.</study_design>
      <phase>3</phase>
      <hc_freetext>Gag reflex.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: The receiving group of mucous adhesive containing 2% lidocaine.                                                                                                             There are 57 samples in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. Then 2% active ingredients are added to the base of mucous adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company.These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA) and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP). Intervention 2: Intervention group2: The receiving group of mucous adhesive containing zinc acetate 2%.                                      There are 57 samples in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. Then 2% active ingredients are added to the base of mucous adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company.These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA) and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP). Intervention 3: Intervention group3: The receiving group of mucous adhesive containing 2% tannic acid.                                        There are 57 samples in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. Then 2% active ingredients are added to the base of mucous adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company.These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA) and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP). Intervention 4: Control group:  People receive placebo. 57 samples participate in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company. These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA), and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hosna Seyedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, in front of the post office, above Shora St., Dr. Shariati St.</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6713954658</zip>
        <telephone>+98 83 3729 6591</telephone>
        <email>hosna.seyedi@kums.ac.ir</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hosna Seyedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, in front of the post office, above Shora St., Dr. Shariati St.</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6713954658</zip>
        <telephone>+98 83 3727 7030</telephone>
        <email>hosna.seyedi@kums.ac.ir</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a gag reflex when placing the radiology film in the mouth
Be over 18 years old
Having consent to enter the research</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who have any central and peripheral nerve damage
Patients with any oral lesions
Patients with a history of substance abuse</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: The receiving group of mucous adhesive containing 2% lidocaine.                                                                                                             There are 57 samples in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. Then 2% active ingredients are added to the base of mucous adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company.These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA) and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP)</i_keyword>
      <i_keyword>Intervention group2: The receiving group of mucous adhesive containing zinc acetate 2%.                                      There are 57 samples in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. Then 2% active ingredients are added to the base of mucous adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company.These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA) and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP)</i_keyword>
      <i_keyword>Intervention group3: The receiving group of mucous adhesive containing 2% tannic acid.                                        There are 57 samples in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. Then 2% active ingredients are added to the base of mucous adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company.These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA) and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP)</i_keyword>
      <i_keyword>Control group:  People receive placebo. 57 samples participate in this group. Hydroxypropyl Methyl Cellulose (HPMC), Polyvinyl chloride (PVC) and Hydroxyethyl cellulose (HEC) polymers are used as the base of the mucous adhesive to make adhesives. The dosage is 2gram per use. It is used once for each sample.Placebo is placed in the form of oral adhesive by means of a swap in the distal teeth 7 and 8 on the upper right or left on the soft and hard palate for 5-10 minutes and then the gag reflex is measured.The polymers used are made by germany's merck company. These adhesive gels are checked in terms of basic specifications. The physicochemical characteristics of the adhesive gels are checked. The microbial control test is performed on the adhesive gels. The viscosity and Ph tests are performed on the adhesive gels. These adhesives do not have any harm to patients. All the materials and bases used in these adhesive mucus formulations are approved by the Food and Drug Administration (FDA), and are of a pharmaceutical grade that is not toxic to humans. Reference: American Pharmacopoeia (USP)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The degree of gag reflex of all participant samples is based on a self-reported scale by placing intraoral radiology film in their mouths. Timepoint: In the first step, the degree of gag reflex of all samples is recorded.5 minutes after the first stage, in the second stage, after 5-10 minutes of adhesive intervention, the gag reflex is measured using the same scale. Method of measurement: How to score the intensity of the gag reflex by the patient and with the help of a visual analog scale (absence of gag reflex, zero, very weak gag reflex, number 1, weak gag reflex, number 2, moderate gag reflex, number 3, severe gag reflex, number 4, and the most severe reflex, number 5) is done.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-11</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>2nd floor, Hoor Building, 236 Alley, Pamchal Ave, Pardis Town Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
